Hofseth BioCare ASA (OSL:HBC)
Norway · Delayed Price · Currency is NOK 1.520
0.00 (0.00%)
Dec 2, 2025, 4:25 PM CET
Hofseth BioCare ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -130.32 | -125.3 | -106.68 | -137.39 | -126.46 | -102.09 | Upgrade |
Depreciation & Amortization | 32.23 | 32.79 | 29.87 | 24.41 | 25.72 | 23.36 | Upgrade |
Other Amortization | 6.99 | 6.99 | 6.54 | 5.81 | 3.63 | 3.41 | Upgrade |
Loss (Gain) From Sale of Assets | 0.09 | -8.12 | -23.49 | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 0.19 | - | - | Upgrade |
Loss (Gain) on Equity Investments | 1.95 | 7.48 | 2.54 | -0.2 | -0.03 | 0.78 | Upgrade |
Other Operating Activities | 164.73 | 159.68 | 9.49 | 9.95 | 9.39 | 8.66 | Upgrade |
Change in Accounts Receivable | 6.73 | -4 | -0.78 | -3.98 | 4.18 | -8.73 | Upgrade |
Change in Inventory | -10.46 | 26.63 | 33.98 | -25.71 | -17.51 | -39.32 | Upgrade |
Change in Accounts Payable | 59.31 | 38.47 | -90.59 | 70.36 | 39.21 | 55.25 | Upgrade |
Change in Other Net Operating Assets | -152.62 | -144.4 | 141.87 | 11.4 | 0.1 | -2.96 | Upgrade |
Operating Cash Flow | -21.39 | -9.78 | 2.76 | -45.17 | -61.78 | -61.63 | Upgrade |
Capital Expenditures | -9.99 | -2.44 | -8.19 | -4.02 | -22.92 | -32.58 | Upgrade |
Sale (Purchase) of Intangibles | -1.72 | -1.63 | -5.87 | -13.76 | -14.83 | -21.88 | Upgrade |
Investment in Securities | - | - | -1.62 | - | -0.19 | -5.6 | Upgrade |
Other Investing Activities | -0 | -0 | 0.69 | - | - | - | Upgrade |
Investing Cash Flow | -11.71 | -4.07 | -14.99 | -17.78 | -37.94 | -60.06 | Upgrade |
Short-Term Debt Issued | - | 19.4 | 28.35 | - | - | - | Upgrade |
Long-Term Debt Issued | - | 25.1 | - | - | 1.09 | 39.02 | Upgrade |
Total Debt Issued | 101.75 | 44.5 | 28.35 | - | 1.09 | 39.02 | Upgrade |
Long-Term Debt Repaid | - | -12.98 | -14.18 | -15.05 | -14.89 | -70.64 | Upgrade |
Net Debt Issued (Repaid) | 95.84 | 31.52 | 14.17 | -15.05 | -13.8 | -31.62 | Upgrade |
Issuance of Common Stock | - | - | - | 70.78 | - | 245.65 | Upgrade |
Other Financing Activities | -20.65 | -15.98 | -10.48 | -10.28 | -9.39 | -14.06 | Upgrade |
Financing Cash Flow | 75.19 | 15.54 | 3.69 | 45.45 | -23.2 | 199.97 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | 0 | - | Upgrade |
Net Cash Flow | 42.1 | 1.69 | -8.54 | -17.49 | -122.91 | 78.28 | Upgrade |
Free Cash Flow | -31.37 | -12.22 | -5.43 | -49.19 | -84.7 | -94.21 | Upgrade |
Free Cash Flow Margin | -12.60% | -4.60% | -2.49% | -40.84% | -96.67% | -136.03% | Upgrade |
Free Cash Flow Per Share | -0.08 | -0.03 | -0.01 | -0.13 | -0.24 | -0.28 | Upgrade |
Cash Interest Paid | 20.65 | 15.69 | 9.49 | 9.95 | 9.39 | 8.58 | Upgrade |
Levered Free Cash Flow | 8.22 | 21.85 | -100.88 | -72.21 | -65.15 | -94.57 | Upgrade |
Unlevered Free Cash Flow | 21.11 | 31.66 | -96.16 | -65.99 | -59.28 | -88.81 | Upgrade |
Change in Working Capital | -97.04 | -83.31 | 84.49 | 52.06 | 25.97 | 4.25 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.